Release – Golden Predator Mining (NTGSF)(GPY:CA) – Announces Termination of Arrangement Agreement with Viva Gold Corp


Golden Predator Mining Corp. Announces Termination of Arrangement Agreement with Viva Gold Corp

 

VANCOUVER, British Columbia, May 03, 2021 (GLOBE NEWSWIRE) — Golden Predator Mining Corp. (TSX.V: GPY; OTCQX: NTGSF(“Golden Predator“) announces that the Company and Viva Gold Corp. (“Viva Gold”) have mutually agreed to terminate the arrangement agreement dated March 2, 2021 for the proposed acquisition of all of the issued and outstanding shares of Viva Gold by Golden Predator. Golden Predator also advises, regardless of the terminated Agreement with Viva Gold, Golden Predator will proceed with its plans to distribute 8,620,000 common shares of C2C Gold Corp. to shareholders of record of Golden Predator Mining Corp. by way of a return of capital transaction. A date of record will be announced.

Golden Predator will continue to focus on advancing its Brewery Creek project in the Yukon through the permitting renewal process. The Company is working with the Yukon Department of Energy, Mines and Resources, and the Yukon Water Board to renew its mining and water use licenses, with the ongoing support of the Tr’ondek Hwech’in First Nation.

ABOUT GOLDEN PREDATOR MINING CORP.
Golden Predator is advancing the past-producing Brewery Creek Mine towards a timely resumption of mining activities in Canada’s Yukon. The project has established resources grading over 1.0 g/t Gold and both a technical report and Bankable Feasibility Study underway to define the economics of a restart of heap leach operations at the Brewery Creek Mine. The 180 km2 brownfield property is located 55 km by road from Dawson City, Yukon and operates under a Socio-Economic Accord with the Tr’ondëk Hwëch’in First Nation. The Company also holds the Marg Project, with a 43-101 compliant resource, the Gold Dome Project and Grew Creek Project. For additional information on Golden Predator and the Brewery Creek Mine, please visit our website: www.goldenpredator.com.

FOR ADDITIONAL INFORMATION:

GOLDEN PREDATOR MINING CORP.
Janet Lee-Sheriff, Chief Executive Officer
(604) 260-0289
[email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

Release – Gevo (GEVO) – Total Cray Valley and Gevo to further Scale Up Development of Renewable Isoamylene from Fusel Oil


Total Cray Valley and Gevo to further Scale Up Development of Renewable Isoamylene from Fusel Oil

 

ENGLEWOOD, Colo., May 03, 2021 (GLOBE NEWSWIRE) — Total Cray Valley and Gevo, Inc. (NASDAQ: GEVO) announced today the successful completion of phase 1 of their Joint Development Agreement (JDA) to upgrade fusel oils into renewable isoamylene. The companies are now seeking to advance to Phase 2 of the JDA, which will allow for scale up of Gevo’s technology at a demonstration scale.

Fusel oils, made during the production of ethanol, equate to approximately 1 million tons of bio-based feedstock. The JDA, signed in 2020, is based on Gevo’s chemical-based catalytic processes that selectively convert low-value fusel oils, a mixture of alcohols that are byproducts from fermentation processes such as ethanol or isobutanol production, into higher-value renewable chemicals such as isoprene, ketones, aldehydes, or olefins, in this case isoamylene.

Isoamylene is used in a diverse set of applications, including resins, pesticides, flavors and fragrances, pharmaceuticals, healthcare products, adhesives, antioxidants, and UV stabilizers. For Cray Valley, isoamylene is used as a raw material in resin manufacturing.

“We were very satisfied with the results of pilot tests during Phase 1. Gevo’s technology was found to be robust and flexible and the initial economic assessment shows potential for a profitable business” said Valérie Goff, Senior Vice President Polymers at Total “This JDA between Total Cray Valley and Gevo is an excellent example of collaboration to develop the materials of the future produced from bio-based feedstock and meets a strong demand from our customers.”

“The team has achieved an important milestone with the success of Phase 1 to deliver plant based, low carbon solutions to our partner, Total Cray Valley. We look forward to continuing our track record of success at the demonstration scale,” stated Dr. Paul Bloom, Chief Technology and Innovation Officer at Gevo . Dr. Bloom continued, “This is a new way to think about decarbonization and biogenic carbon sequestration. Now this byproduct from ethanol, instead of being burned, can be converted into usable products that take CO out of the atmosphere while delivering drop-in performance in final products on the market today. For every pound of biobased isoamylene made and used in durable products like resins, it is essentially the equivalent of sequestering 2.5 pounds of biogenic CO from the atmosphere, compared to that carbon being combusted. Another example of how Gevo is advancing our focus to net zero and beyond.”

The companies are currently exploring options for scale-up and commercialization of the technology, which would provide the US market with a renewable source of isoamylenes, a world first.

About Total Cray Valley

Total Cray Valley is the premier global supplier of specialty chemical additives, hydrocarbon specialty chemical, and liquid and powder tackifying resins used as ingredients in adhesives, rubbers, polymers, coatings and other materials. Total Cray Valley has pioneered the development of these advanced technologies, introducing hundreds of products that enhance the performance of products in energy, printing, packaging, construction, tire manufacture, electronics, and other demanding applications. For more information, please visit www.crayvalley.com .

About Total

Total is a broad energy company that produces and markets fuels, natural gas and electricity. Our 100,000 employees are committed to better energy that is more affordable, more reliable, cleaner and accessible to as many people as possible. Active in more than 130 countries, our ambition is to become the responsible energy major.

About Gevo

Gevo’s mission is to transform renewable energy and carbon into energy-dense liquid hydrocarbons. These liquid hydrocarbons can be used for drop-in transportation fuels such as gasoline, jet fuel and diesel fuel, that when burned have potential to yield net-zero greenhouse gas emissions when measured across the full life cycle of the products. Gevo uses low-carbon renewable resource-based carbohydrates as raw materials, and is in an advanced state of developing renewable electricity and renewable natural gas for use in production processes, resulting in low-carbon fuels with substantially reduced carbon intensity (the level of greenhouse gas emissions compared to standard petroleum fossil-based fuels across their life cycle). Gevo’s products perform as well or better than traditional fossil-based fuels in infrastructure and engines, but with substantially reduced greenhouse gas emissions. In addition to addressing the problems of fuels, Gevo’s technology also enables certain plastics, such as polyester, to be made with more sustainable ingredients. Gevo’s ability to penetrate the growing low-carbon fuels market depends on the price of oil and the value of abating carbon emissions that would otherwise increase greenhouse gas emissions. Gevo believes that its proven, patented technology enabling the use of a variety of low-carbon sustainable feedstocks to produce price-competitive low-carbon products such as gasoline components, jet fuel and diesel fuel yields the potential to generate project and corporate returns that justify the build-out of a multi-billion-dollar business.

Gevo believes that the Argonne National Laboratory GREET model is the best available standard of scientific-based measurement for life cycle inventory or LCI.


Learn more at Gevo’s website: www.gevo.com

Total Contacts

Media Relations: +33 (0)1 47 44 46 99 l [email protected] l @TotalPress

Investor Relations: +44 (0)207 719 7962 l [email protected]

Gevo Contacts

Investor and Media Relations: +1 720-647-9605 l [email protected]

Cautionary note

This press release, from which no legal consequences may be drawn, is for information purposes only. The entities in which Total SE directly or indirectly owns interests are separate legal entities. Total SE shall not be held liable for their acts or omissions. The terms “Total,” “Total Group” and “Group” may be used in this document for convenience. Similarly, the words “we”, “us” and “our” may also be used to refer to affiliates or to their employees. This document may contain forward-looking information and statements that are based on business and financial data and assumptions made in a given business, financial, competitive and regulatory environment. They may prove to be inaccurate in the future and are subject to a number of risk factors. Neither Total SE nor any of its subsidiaries or affiliates assumes any obligation to investors or other stakeholders to update in part or in full any forward-looking information or statement, objective or trend contained in this document, whether as a result of new information, future events or otherwise.

Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters including, without limitation, the JDA between Gevo, Inc. and Total Petrochemicals & Refining USA, Inc (Total Cray Valley), the ability of the parties to scale up and/or commercialize the fusel oil technology that is the subject of the JDA, and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Gevo and Total Cray Valley are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo and Total Cray Valley undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo and Total Cray Valley believe that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2020, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.

Release – Comtech Telecommunications (CMTL) – Awarded $6.2 Million of Additional Funding to Support the U.S. Army Blue Force Tracking System


Comtech Telecommunications Corp. Awarded $6.2 Million of Additional Funding to Support the U.S. Army’s Blue Force Tracking System

 

MELVILLE, N.Y.–(BUSINESS WIRE)–May 3, 2021– 
May 3, 2021— 
Comtech Telecommunications Corp. (NASDAQ: CMTL), a world leader in secure wireless communications technologies, announced today, that during its third quarter of fiscal 2021, its Government Solutions segment, through its 
Maryland-based subsidiary, 
Comtech Mobile Datacom Corporation, was awarded 
$6.2 million of additional funding for Option Period Four of contract GS03Q17DSC0002. The overall funded value to date, inclusive of the Base and Option Period 1 through Option Period 4, is 
$35.5 million.

This contract modification is part of the BFT-1 sustainment support contract for the 
U.S. Army’s Project Manager Mission Command (“PM MC”) Blue Force Tracking (“BFT-1”) program. 
Comtech continues to perform engineering services, satellite network operations and program management through a Firm Fixed Price (“FFP”) contract, with Time & Materials (“T&M”) and Cost Reimbursement elements. Option Period Four’s performance period began on 
April 15, 2021 and ends on 
April 14, 2022.

“We are pleased our 
U.S. Army continues to recognize the value of Comtech’s services,” said  Fred Kornberg, Chairman of the Board and Chief Executive Officer of 
Comtech Telecommunications Corp. “Our team remains committed to providing the 
U.S. Army and its soldiers with critical BFT-1 sustainment support.”

Comtech Telecommunications Corp. is a leader in the global communications market headquartered in 
Melville, New York. With a passion for customer success, 
Comtech designs, produces and markets advanced secure wireless solutions to more than 1,000 customers in more than 100 countries. For more information, please visit www.comtechtel.com.

Certain information in this press release contains statements that are forward-looking in nature and involve certain significant risks and uncertainties. Actual results could differ materially from such forward-looking information. The Company’s 
Securities and Exchange Commission filings identify many such risks and uncertainties. Any forward-looking information in this press release is qualified in its entirety by the risks and uncertainties described in such 
Securities and Exchange Commission filings.

Media Contact:
Michael D. Porcelain, President and Chief Operating Officer

Comtech Telecommunications Corp.
631-962-7000
[email protected]

Source: 
Comtech Telecommunications Corp.

Release – Avivagen (VIVXF)(VIV:CA) – Announces Recurring Order for OxC-beta Livestock


Avivagen Announces Recurring Order for OxC-beta™ Livestock

 

• Largest purchase amount and longest duration purchase to-date
• Four tonne per month order secured
• Order follows five successful OxC-beta™ Livestock commercial trials conducted with various species over the past six months

Ottawa, ON / Business Wire/ May 3, 2021 / Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, is pleased to announce that Meyenberg International Group, Avivagen’s consultant in Mexico, has entered into a contract which secures a four tonne per month recurring order for OxC-beta™ Livestock in Mexico.

The contract, which is 18 months from signing and includes an order for 500 Kgs delivered April 30th, is a commitment to purchase a minimum of four tonnes monthly, commencing in July, 2021 and ending October, 2022

“As we continue to see successful commercial trials conclude in those jurisdictions where OxC-beta™ Livestock is approved, we anticipate increased demand to follow, as has recently been demonstrated in Mexico and Thailand,” said Kym Anthony, Chief Executive Officer of Avivagen.  “With numerous other commercial trials currently underway and nearing completion, it is our belief that the continued success of such company conducted trials will help to accelerate the adoption and use of OxC-beta™ Livestock in approved jurisdictions and beyond. It is our belief that OxC-beta™ Livestock, once started by a customer, becomes core to their continued operations and will drive recurring orders for years to come.”

Meyenberg International Group
With a client base across North America and a well-earned reputation for enabling rapid growth for clients expanding into LATAM, Meyenberg’s experience in Mexico has enabled Avivagen to quickly establish and grow sales in the country since securing regulatory approval in August 2019.

About OxC-beta™ Technology and OxC-beta™ Livestock
Avivagen’s OxC-beta™ technology is derived from Avivagen discoveries about ?-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colours. Through support of immune function the technology provides a non-antibiotic means of promoting health and growth. OxC-beta™ Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds. The product is currently available for sale in the United States, Philippines, Mexico, Taiwan, New Zealand, Thailand, Brazil, Australia and Malaysia.

Avivagen’s OxC-beta™ Livestock product is safe, effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters. Numerous international livestock trials with poultry and swine using OxC-beta™ Livestock have proven that the product performs as well as, and, sometimes, in some aspects, better than in-feed antibiotics.

About Avivagen
Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance.  It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada. For more information, visit www.avivagen.com. The contents of the website are expressly not incorporated by reference in this press release.

Forward Looking Statements
This news release includes certain forward-looking statements that are based upon the current expectations of management. Forward-looking statements involve risks and uncertainties associated with the business of Avivagen Inc. and the environment in which the business operates. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions aim”, anticipate”, appear”, believe”, consider”, could”, estimate”, expect”, if”, intend”, goal”, hope”, likely”, may”, plan”, possibly”, potentially”, pursue”, seem”, should”, whether”, will”, would” and similar expressions. Statements set out in this news release relating to the recurring nature of the orders under the contract described above, the anticipated date of fulfillment for the order described,  Avivagen’s expectation that the customer in question will live up to its contractual commitment to purchase product monthly, anticipated increase in demand for Avivagen’s products,  Avivagen’s expectation that commercial trials currently underway will be completed and yield positive results, the anticipated impact of the results of such trials on demand for product, expectations as to the recurring and long term nature of a customer’s purchases once they begin using Avivagen’s products and  the possibility for OxC-beta™ Livestock to replace antibiotics in livestock feeds as well as fill a critical need for health support in certain livestock applications where antibiotics are precluded are all forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. For instance, the order described may not result in new orders for Avivagens products,  the customer plans may change due to many reasons, timing of fulfillment of the order may be delayed beyond current expectation for a number of reasons which would push fulfillment and recognition of revenues for this order into a future quarter or cause such order to be cancelled, the parties to the contract described may not live up to their contractual commitments and/or may agree to amend such contract to reduce the commitments described above, demand for Avivagens products may not continue to grow and could decline,  commercial trials may not be completed and, if completed, may not yield results that are positive or which lead to additional demand for Avivagen’s products, except as otherwise stated, customers are under no obligation to continue using Avivagen’s products and Avivagens products may not gain market acceptance or regulatory approval in new jurisdictions or for new applications, including human applications, and may not be widely accepted as a replacement for antibiotics in livestock feeds, , in each case due to many factors, many of which are outside of Avivagens control.  Readers are referred to the risk factors associated with the business of Avivagen set out in Avivagens most recent managements discussion and analysis of financial condition available at www.SEDAR.com. Except as required by law, Avivagen assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information:
Avivagen Inc.
Drew Basek
Director of Investor Relations
100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6
Phone: 416-540-0733
E-mail: [email protected]

Kym Anthony
Chief Executive Officer
100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6
Head Office Phone: 613-949-8164
Website: www.avivagen.com

Release – TAAL Distributed Information Technologies (TAALF) – Files 2020 Fiscal Year-End Financial Results And Provides Operational Guidance For 2021


TAAL Files 2020 Fiscal Year-End Financial Results And Provides Operational Guidance For 2021

 

Vancouver, British Columbia; April 30, 2021 – TAAL Distributed Information Technologies Inc. (CSE:TAAL | FWB:9SQ1 | OTC:TAALF) (“TAAL” or the “Company”), a vertically integrated blockchain infrastructure and service provider for enterprise, announced today its financial results and Management Discussion and Analysis for the fiscal year ended December 31, 2020. These filings are available for review on the Company’s SEDAR profile at www.sedar.com and on the Company’s website at www.taal.com. All financial information in this press release is reported in Canadian dollars unless otherwise indicated.
 

SUBSEQUENT TO YEAR-END

 

  • As of March 31, 2021, TAAL had approximately 74,000 BitcoinSV (“BSV”) in treasury
  • Based on current network conditions, TAAL anticipates winning at least 30 blocks per day attributable to TAAL
    • Each block currently paying 6.25 BitcoinSV as a reward
    • TAAL pool averaged 45 blocks a day in Q1 2021
  • On March 18th, TAAL closed an oversubscribed prospectus offering for aggregate gross proceeds of approximately $40 Million
  • On March 13th, TAAL processed a world record 638MB block on the BSV blockchain network
  • Hashing operations commenced in Canada in Q1 of 2021.

 

2020 OVERVIEW

 
2020 was a year of groundwork for TAAL in transitioning its business towards the goal of becoming a world leader in blockchain infrastructure and transaction processing.

The Company purchased new blockchain computers, which are anticipated to help the Company reach its 2021 goal of 400 petahash, owned and controlled by TAAL, on the BSV blockchain network once fully deployed.

Also, in 2020, TAAL expanded its enterprise blockchain infrastructure services with its acquisition of WhatsOnChain. WhatsOnChain owns proprietary BitcoinSV blockchain explorer technology developed by its founders, who created the first-ever BSV block explorer to provide data in an easy and user-friendly manner.

Q3 2020 saw a new TAAL office in Zug, Switzerland, and key hires in c-suite and senior management roles. In connection with the Zug office opening, TAAL onboarded several key new hires to expand the Company’s operations, including a new President, Chief Operating Officer, Chief Technology Officer, Chief Compliance Officer. In addition, Q4 2020 saw the election of two new members to its Board of Directors, and  Mr. Stefan Matthews, the Chairman of the Company’s board of directors, took on the Chief Executive Officer position and is now serving as Executive Chairman and Chief Executive Officer.

Stefan Matthews, TAAL’s CEO and Executive Chairman, commented that

“2020 was a year of transition for TAAL. Despite the challenges of the global pandemic, 2020 marked multiple and significant milestones for TAAL in building the infrastructure, capacity, and global expertise to enable us to execute our strategic plan. We see evidence of Blockchain technology moving significantly closer to mass adoption. Our infrastructure and product innovations, built on the BitcoinSV protocol with its scalability and ultra-low transaction fee advantages, position us to enable enterprise transformation across global markets using this technology. I congratulate our entire team on their hard work and commitment towards preparing TAAL to be a  global blockchain leader.”

 

NEW WEBSITE ANNOUNCEMENT 2021

 
TAAL recently launched its newly designed website, designed to enhance clients’ online experience and provide an easier way for investors to learn about TAAL (taal.com).
 

ABOUT TAAL DISTRIBUTED INFORMATION TECHNOLOGIES INC.

 
TAAL Distributed Information Technologies Inc. delivers value-added blockchain services, providing professional-grade, highly scalable blockchain infrastructure and transactional platforms to support businesses building solutions and applications upon the BitcoinSV platform, and developing, operating, and managing distributed computing systems for enterprise users.

Visit TAAL online at www.taal.com

The CSE, nor its Regulation Services Provider, accepts no responsibility for the adequacy or accuracy of this release.
 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

 
Certain statements included in this news release constitute “forward-looking information” as defined under applicable Canadian securities legislation. The words “will”, “intends”, “expects” and similar expressions are intended to identify forward-looking information, although not all forward-looking information will contain these identifying words. Specific forward-looking information contained in this news release includes but is not limited to statements regarding: the growth of TAAL’s treasury through, among other things, BSV hashing activities; TAAL Pool’s anticipated hashing activity; TAAL’s future computing power and capacity; and TAAL’s business and strategic plans. These statements are based on factors and assumptions related to historical trends, current conditions and expected future developments. Since forward-looking information relates to future events and conditions, by its very nature it requires making assumptions and involves inherent risks and uncertainties. TAAL cautions that although it is believed that the assumptions are reasonable in the circumstances, these risks and uncertainties give rise to the possibility that actual results may differ materially from expectations. Material risk factors include the future acceptance of Bitcoin SV and other digital assets and risks related to information processing using those platforms, the ability for TAAL to leverage intellectual property into viable income streams and other risks set out in TAAL’s Annual Information Form dated April 30, 2021 under the heading “Risk Factors” and elsewhere in TAAL’s continuous disclosure filings available on SEDAR at www.sedar.com. Given these risks, undue reliance should not be placed on the forward-looking information contained herein. Other than as required by law, TAAL undertakes no obligation to update any forward-looking information to reflect new information, subsequent or otherwise.
 

FOR FURTHER INFORMATION CONTACT:

 
Matt Whitcomb, Investor Relations, [email protected] 604-260-6142

Stefan Matthews, CEO & Executive Chairman, [email protected]

Chris Naprawa, President, [email protected]

Release – Ocugen (OCGN) – Announces studies showing COVAXIN potentially effective against three key variants of SARS-CoV-2


Ocugen announces studies showing COVAXIN potentially effective against three key variants of SARS-CoV-2

 

  • COVAXIN effectively neutralizes Brazil variant along with UK variant and India double mutant variant

  • Potential effectiveness against multiple variants reduces the possibility of mutant virus escape

  • According to World Health Organization, the double mutant variant of SARS-CoV-2 has spread to at least 17 countries

MALVERN, Pa., May 03, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that in a new study, scientists at Indian Council of Medical Research (ICMR)-National Institute of Virology have found that COVAXIN demonstrated potential effectiveness against the Brazil variant of SARS-CoV-2, B.1.128.2. As previously disclosed, a study conducted by ICMR also suggested that COVAXIN was effective against the UK variant, B.1.1.7, as well as the Indian double mutant variant, B.1.617. It is notable that the Brazilian variant, B1.128.2, contains the E484K mutation that was found in New York.

In the ICMR studies, COVAXIN-vaccinated sera effectively neutralized several SARS-CoV-2 variants (B.1.617 (India, double mutant), B.1.1.7 (United Kingdom), B.1.1.28 (Brazil P2), and heterologous strain) in an in-vitro plaque reduction neutralization assay. These studies suggest that COVAXIN vaccination may be effective against multiple SARS-CoV-2 variants.

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

“We are pleased to see the results of this study as it demonstrates the potential effectiveness of COVAXIN against multiple variants, further strengthening our belief that this vaccine can potentially eliminate the possibility of mutant virus escape,” said Dr. Satish Chandran, chair of the vaccine scientific advisory board of Ocugen.

“COVAXIN continues to show strong results in all the studies conducted to date. We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic. The Ocugen team submitted a comprehensive drug master file with the FDA and is currently diligently preparing the EUA application,” said Dr. Shankar Musunuri, Chairman of the Board, Chief Executive Officer, and Co-founder of Ocugen.

Ocugen is developing COVAXIN, Bharat Biotech’s COVID-19 vaccine candidate, for the U.S. market. In the recently shared second interim results of the Phase 3 clinical trial, COVAXIN demonstrated 78% overall efficacy and 100% in severe COVID-19 disease (including hospitalization).

About COVAXIN

COVAXIN, India’s COVID-19 vaccine by Bharat Biotech, is developed in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). COVAXIN is a highly purified and inactivated vaccine that is manufactured using a vero cell manufacturing platform with an excellent safety track record of more than 300 million doses supplied.

In addition to generating strong immune response against multiple antigens, COVAXIN has been shown to generate memory T cell responses, for its multiple epitopes, indicating longevity and a rapid antibody response to future infections. With published data demonstrating a safety profile superior to available data for several other vaccines, COVAXIN is packaged in multi-dose vials that can be stored at 2-8?C.

About Ocugen, Inc.

Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug – “one to many” and our novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. We are co-developing Bharat Biotech’s COVAXIN™ vaccine candidate for COVID-19 in the U.S. market. For more information, please visit www.ocugen.com.

About Bharat Biotech

Bharat Biotech has established an excellent track record of innovation with more than 145 global patents, a wide product portfolio of more than 16 vaccines, 4 bio-therapeutics, registrations in more than 123 countries, and the World Health Organization (WHO) Pre-qualifications. Located in Genome Valley in Hyderabad, India, a hub for the global biotech industry, Bharat Biotech has built a world-class vaccine & bio-therapeutics, research & product development, Bio-Safety Level 3 manufacturing, and vaccine supply and distribution.

Having delivered more than 4 billion doses of vaccines worldwide, Bharat Biotech continues to lead innovation and has developed vaccines for influenza H1N1, Rotavirus, Japanese Encephalitis, Rabies, Chikungunya, Zika, and the world’s first tetanus-toxoid conjugated vaccine for Typhoid. Bharat’s commitment to global social innovation programs and public-private partnerships resulted in introducing path-breaking WHO pre-qualified vaccines BIOPOLIO®, ROTAVAC®, and Typbar TCV® combatting polio, rotavirus, typhoid infections, respectively. The acquisition of the rabies vaccine facility, Chiron Behring, from GlaxoSmithKline (GSK) has positioned Bharat Biotech as the world’s largest rabies vaccine manufacturer. To learn more about Bharat Biotech, visit www.bharatbiotech.com.

Cautionary Note on Forward-Looking Statements

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. We may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such forward-looking statements include information about qualitative assessments of available data, potential benefits, expectations for clinical trials, and anticipated timing of clinical trial readouts and regulatory submissions. This information involves risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as risks associated with preliminary and interim data (including the Phase 3 interim data), including the possibility of unfavorable new clinical trial data and further analyses of existing clinical trial data; the risk that clinical trial data are subject to differing interpretations and assessments, including during the peer review/publication process, in the scientific community generally, and by regulatory authorities; whether and when data from Bharat Biotech’s clinical trials will be published in scientific journal publications and, if so, when and with what modifications; whether the U.S. Food and Drug Administration (FDA) will be satisfied with the design of and results from preclinical and clinical studies of COVAXIN, which have been conducted by Bharat Biotech in India; whether and when any biologics license and/or emergency use authorization applications may be filed in the United States for COVAXIN; whether and when any such applications may be approved by the FDA; decisions by the FDA impacting labeling, manufacturing processes, safety and/or other matters that could affect the availability or commercial potential of COVAXIN in the United States, including development of products or therapies by other companies. These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (SEC), including the risk factors described in the section entitled “Risk Factors” in the quarterly and annual reports that we file with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events or otherwise, after the date of this press release.

Ocugen Contact:
Ocugen, Inc.
Sanjay Subramanian
CFO and Head of Corp. Dev.
[email protected]


Media Contact:
LaVoieHealthScience
Lisa DeScenza
[email protected]
+1 9783955970

Winners and Losers with Low Interest Rates


The Fed Doubles Down on Keeping Rates Down – Winners and Losers

 

“I guess I should warn you, if I turn out to be particularly clear, you’ve probably misunderstood what I said.”  – Alan Greenspan

 

The announced move by the Federal Reserve last week to keep the interest rates it has control over steady was not a surprise to those that can translate today’s Fed-speak. In the past, two or more announcements Fed Chair Powell’s comments have been very consistent about being a long way from raising interest rates and they are wanting to see significant improvement in the labor market and inflation sustained above 2 percent before any tapering or tightening. In Fed-speak this means, well, it means exactly what he said. Fed Chair Powell has been abundantly clear and has not thrown the market any curveballs since being appointed. With this in mind, consider that by last measure inflation stood at 1.8%, unemployment at an unacceptable 6% and that is not including the 2 million fewer Americans in the labor force (relative to pre-covid).

 

What it Could Mean for You

As an investor, as someone that is an active producer and consumer in the economy, you may want to ask yourself, not what the Fed statement means, but “what does it mean to me?”  How can I take advantage of their plan, how do I avoid being hurt, what investment sectors could continue to do well because of low rates, and even what should be the course of action if rates tick up? To be more direct, Fed Chair Jay Powell has said that highly accommodative monetary policy will continue for the foreseeable future. Ask, who wins and who loses, how can I benefit?

To better understand the complete Fed actions, remember the central bank has also taken steps to keep longer interest rates near its target range too. They’ve injected hundreds of billions of dollars into the system through securities repurchases. The Fed has had a seemingly unlimited pot to pull from to buy Treasuries and even mortgage-backed securities at more expensive levels than the market. Previously it announced that it held unlimited bond-buying abilities.

As there seems little doubt that the  Fed will continues to sit tight on 0%-.25% overnight and other very low targets, here is who can be expected to benefit and who may lose from the ongoing promise by the Fed.

 

Bank Deposits

The Fed funds rate is what banks charge each other to borrow reserves from each other overnight. So a 0%-.25% Fed funds rate is what you are competing with on your savings and longer-term Certificates of Deposit (CDs). CD rates saw a substantial decline after the Fed lowered rates in early 2020.

CD owners locking in rates now will have to commit to earning those rates for the term of the CD. The Fed promised low rates through next year, those not beating the 1.8% inflation rate may be worse off.

Savings accounts are paying just above zero. It’s important to note that the return (within limits) is guaranteed by the FDIC. Other than U.S. Treasury securities, this kind of assurance is largely unavailable, so if you expect negative returns on alternatives, this is an easy safe harbor. If this level of security is important to the saver, shopping online for the best rate makes more sense than settling for the rate of the bank down the road. Remember the rate may only be slight;y more, but after compounding over the years the difference is more impactful.

 

Mortgages

The Fed funds rate doesn’t directly impact mortgage rates. But they do set the starting rate in the yield curve which measures risk-free (U.S. Treasury) rates through 30 years. Thirty-year mortgages are generally spread to 10-year U.S. Treasury notes. This is because their durations (average time to repayment) are similar. This has kept mortgage rates exceedingly low, as an added bonus the Fed remains a buyer of mortgage-backed securities, this demand helps keep mortgage rates low.

This low-rate environment makes winners of those getting a mortgage or able to refinance. Those with adjustable-rate mortgages also have benefitted from low rates. Demand for mortgages has surged over the past year as low rates have increased demand. Those owning mortgage securities have benefitted from the bond bull market.

 

Investors in Stocks

The Fed’s near-zero interest rate policy and open-ended buying of bonds provide both money for equity investors and few alternatives other than the stock market.

Low rates are likely to keep a floor under stocks. After the market drop in stocks following the novel coronavirus in the U.S., the government’s reaction has caused stocks to spring back and then some. The Standard & Poor’s 500 Index sits near all-time highs. More attractive alternative investments for all the money created are few. 

 

The Federal Government

Those that borrow embrace low interest rates because their payments are based on a lower rate. There is no bigger borrower than the U.S Federal government. As the national debt passes $28 trillion, low rates allow higher rate debt rolling off to be refinanced at lower rates. This saves billions of dollars in interest. According to the Congressional Budget Office, the U.S. government increased the national debt by an additional $3.1 trillion in the last fiscal year (ended Sept. 30, 2020). Low rates mean the borrowing cost of spending more remains is less costly at this time.

Increased borrowing and lower return have hurt the value of the $US dollar. Exchange rates versus other large currencies and even many cryptocurrencies have weakened the greenback over the last year. Declining exchange rates tend to lower how much those savvy with their finances want to hold U.S. dollar-denominated securities.

 

 

Home Equity

Homeowners have mostly seen the price of their real estate rise. The cost of a home equity line of credit (HELOC) remains low since HELOCs adjust in synch to changes in short-term rates.

Since rates on HELOCs remain low, those with outstanding balances on their lines of credit will continue to have low-interest expenses and options.

 

Credit Card Debt

Many variable-rate credit cards change the rate they charge customers based on the prime rate, which is banks tend to adjust relative to the Fed funds rate. The Fed’s announced position to keep overnight rates low for an extended period means that interest on variable-rate cards is

 

Take-Away

The Fed is looking for fuller employment and a hot economy. They are adding money to the system, reducing the cost of spending, and creating few alternatives better than owning equity investments and real property. The US dollar weakening has the effect of lowering the buying power of any investment return, but liquidity is running high in both markets. For low return savings such as bank deposits, the erosion of US currency may exceed their return on the savings.

 

Suggested Reading:

Do Microcap Stocks Provide Better Diversification?

Seeking Alpha Subscribers are Seeking Answers About Their New Paywall Policy



Will Janet Yellen be Good for Investors

Will the US Continue to Subsidize Alternative Energy?

 

Picture Credit: Robert Scoble, Credit Card of Future

 

Stay up to date. Follow us:

           


Stay up to date. Follow us:

QuickChek – April 30, 2021



Milestone Reached as Gevo Breaks Ground on Renewable Natural Gas Project in Northwest Iowa

Gevo announced that is has officially broken ground on the Renewable Natural Gas Project, located in Northwest Iowa, which will generate RNG captured from dairy cow manure

Research, News & Market Data on Gevo

Watch recent presentation from NobleCon17



Online Media is Within an Hour of Becoming Main-Stream Media

Have you guessed which outlet has grown by 460% ?



Bert Alfonso Named Executive Vice President and CFO

Information Services Group announced that David Berger, Executive VP and CFO, will retire after nearly 12 years of service with the firm and that Humberto “Bert” Alfonso has been named to succeed him, effective June 7

Research, News & Market Data on Information Services Group

Watch recent presentation from NobleCon17



Aurania Confirms New Discovery That Extends Tiria-Shimpia to 22km

Aurania Resources Ltd. reports on the discovery of Shimpia North, an area in which elevated metal values have been found in streams draining a ridge that is seven kilometres long. Shimpia North is an extension to the high-grade silver-zinc-lead mineralization at Tiria-Shimpia in the Company’s Lost Cities – Cutucu Project in southeastern Ecuador.

Research, News & Market Data on Aurania Resources

Watch recent presentation from NobleCon17

Stay up to date. Follow us:

Online Media is Within an Hour of Becoming Main-Stream Media

 


Online Media is Within an Hour of Becoming Main-Stream Media

 

The clock is ticking on broadcast radio and TV as the technology is becoming dated relative to the greatly accelerated use of mobile devices and growth (albeit slower) of desktop computing.

Since 2011, media consumption for U.S. adults is up 20% across all categories.

One of those categories has grown by 460%. To have earned that growth, quite a bit of erosion was from TV and traditional radio.

Have you guessed which outlet has grown so dramatically?

An average of 4 hours and 12 minutes is spent on mobile devices compared to only 45 minutes just ten years ago.

Take a look at the graphic below; it demonstrates just how quickly habits change.

 

Graphics by Visual Capitalist

 

From a business perspective, adaption is key to growth and critical for survival.  In this case, understanding and satisfying changing audience preferences need to be part of the business plans of all doing business in the industry(s) represented above.

Photo by Allen, no changes were made

What’s the Future of Media Consumption

Esports Investors Better Able to Evaluate Stocks


Stay up to date. Follow us:

           


Stay up to date. Follow us:

Information Services Group (III) – ISG Announces David Berger to Retire as CFO in June; Bert Alfonso Named Executive Vice President and CFO


ISG Announces David Berger to Retire as CFO in June; Bert Alfonso Named Executive Vice President and CFO

 

Alfonso Brings Extensive Financial, Capital Markets and Global M&A Experience to ISG

Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, announced today that David Berger, executive vice president and chief financial officer, will retire after nearly 12 years of service with the firm and that Humberto “Bert” Alfonso has been named to succeed him, effective June 7.

Berger will remain with the firm for several months in an advisory role to assist in ongoing M&A projects and to support the transition. He joined ISG in 2009 as executive vice president and CFO and played a pivotal role in helping grow ISG through his financial stewardship of the firm and his work on a series of strategic acquisitions.

“On behalf of my ISG colleagues, I want to extend my deepest gratitude to David for his long and valued service to ISG,” said Michael P. Connors, chairman and CEO. “David has been a strong partner and advisor to me and our executive team and has made many contributions to our success over the last 12 years, including building a world-class finance and legal organization to support our growth plans. I want to thank David for his thoughtful retirement transition planning and his support over the coming months. We wish him and his family much happiness in their next chapter.”

Alfonso is a global senior executive with over 30 years of operating and finance experience with such distinguished companies as Hershey, Cadbury Schweppes and Pfizer. He spent 10 years with The Hershey Company in executive roles, including chief financial officer and president of Hershey International. Alfonso has a proven track record of driving growth, both organically and through mergers and acquisitions, building high-performance teams and creating shareholder value.

Alfonso will be responsible for all areas of finance, legal affairs and M&A for ISG, reporting to Connors, and will join the ISG executive leadership team.

“I am delighted to welcome Bert to ISG,” said Connors. “Bert and I have known each other for 10 years and I have been impressed with his business acumen and vast array of experience. His global operating leadership as a CEO, his service as a CFO of a multibillion-dollar company, his M&A accomplishments and his experience leveraging technology services to support business operations will be extremely valuable to ISG as we accelerate our growth coming out of the pandemic. Bert’s character, integrity and demeanor are an excellent fit for our growth ambitions.”

Alfonso most recently was the CEO of Yowie Group, a global brand licensing company specializing in the development of consumer products and listed on the Australian Securities Exchange. Prior to Hershey, he was executive vice president and CFO of Cadbury Schweppes Americas beverages and vice president and CFO of the Adams Division of Pfizer.

A native of Cuba, Alfonso has lived in Argentina, Canada, Puerto Rico, the U.K. and the U.S. He holds an MBA degree in marketing and a bachelor’s degree in accounting from Rutgers University. Alfonso is a certified public accountant and serves on the Board of Directors of the NYSE-listed Eastman Chemical Company and is chairman of the Board’s audit committee.

About ISG

ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 700 clients, including more than 75 of the world’s top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,300 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry’s most comprehensive marketplace data. For more information, visit www.isg-one.com.

Source: Information Services Group

Regulation of a SPAC

 


Regulation of a Special Purpose Acquisition Company
(Part of a Channelchek Series on SPACs)

 

The primary U.S. regulator of publicly traded securities is the Securities and Exchange Commission (SEC). Their role is threefold; they’re responsible for protecting investors, maintaining the fair and orderly function of securities markets, and facilitate capital formation. SPACS are certainly part of capital formation, they are an investment vehicle, and they are traded on securities markets. So SPACs hit squarely on all three main responsibilities. If that isn’t enough to place the regulator as first in line for oversight (state laws, accounting rules, OCC regs could also apply), the SEC also promotes full public disclosure, protects investors against fraudulent and manipulative practices, and monitors corporate takeover actions. It also approves registration statements for bookrunning at underwriting firms. Combined, this places them solidly as the regulator overseeing special purpose acquisition corporations.

Although SPACs are not new offering types, the increased enthusiasm among both sponsors and investors over the past year has caused the SEC to increase their attention on all aspects of the SPAC lifecycle including sales and post-merger or acquisition trading. Regulation of a Special Purpose Acquisition Corporation is the third of a Channelchek series on SPACs. From this installment, you should better understand some of the heightened or unique considerations the SEC has regarding SPACs, including:

  • The unprecedented surge, celebrity-sponsored SPACs, and innovative non-standard SPAC structures
  • Disclosure and information made publicly available so holders and investors are best prepared to make informed investment and voting decisions
  • How SPACs differ from traditional IPOs and whether or not they should
  • Accounting treatment of warrants 

As unique as many aspects of everyone’s work lives have been over the past 13 months, the SEC has had its own unprecedented, out-of-the-blue situations to quickly analyze, understand and determine if actions should be taken to protect investors. This could include “meme-investors” and the market gyrations they promote, broker-dealers halting trading on issues; the SEC halted trading activity in 15 firms themselves, and also an unprecedented surge in SPAC IPOs coming to market.

As it relates to the SPAC IPOs, for the whole process, including after the de-SPAC stage, the SEC has indicated it has some concerns. They have made it clear they are paying attention and they have issued some changes that may reduce the boiling pace of SPAC creation, to a more manageable and sustainable simmer. 

 

SEC Concerns

The SEC in its role of overseeing trading, has issued guidance, voiced some concerns, and changed the way accounting is handled of an important part of the sponsors’ compensation.  Applying existing regulation and making sure safeguards are in place is designed to be good for everyone involved, here we’ll look at concerns that seem to have moderated the SPAC IPO pace for now.

Concerns they have communicated include risks from fees, conflicts of interest, sponsor compensation, celebrity sponsorship and the potential for retail participation drawn by hype, and the sheer amount of capital pouring into SPACs, each of which is designed to hunt for a private target to take public. There is a finite number of targets and presumably a slow level of potential new targets being “born.”

The Securities and Exchange Commission staff are looking at the filing process and disclosures by SPACs and their private targets. According to the SEC, staff professionals are reviewing these filings and may seek clearer disclosure when guidance is provided to registrants and the public. They are focusing their “places for improvement” efforts on SPAC and private target disclosure to allow for the public to make informed investment and voting decisions about SPAC transactions.

An issue they have expressed is that they believe evaluation has been a little different with some SPACs. They have said that forward-looking statements and future expected cash flows are generally considered more important when evaluating a deal rather than what celebrity may be touting the future prospect or other possible hype.  Forward-looking information needs a solid basis to have utility, they suspect putting a celebrity out front as the face of a SPAC may give undo credibility for success. The SEC is concerned that the nature of the transactions relative to a more standard IPO of a private company lends itself to increased levels of speculation and could open the door to fraud. This is especially true if “stars” are brought in to garner attention and also because there is an urgency and time factor that could rush judgment. The issue is heightened not because of cases of misuse of information and projections but because with the sheer amount and size of the transactions may invite potential misuse.  

The SEC is also looking at the trading that goes on at the time of the business combination. Many shares are sold at that time and then wind up in the hands of others.  In other words, many investors in the SPAC’s own initial offering are not the investors in the ultimate public company’s new financial structure and business operations. The SEC has decided that if a major shift in ownership is occurring in most SPACs, just before and after de-SPAC, they should view it as a new speculative entity. Almost as though it is a whole new process.  They’re looking at this with the question in mind, “are additional safeguards needed?”

 

 

Accounting

On April 12, 2021, the SEC released a statement titled Staff
Statement on Accounting
and Reporting Considerations for Warrants
Issued by SPACs
. The statement clarified that SPAC warrants with certain common features must be booked as liabilities rather than equity. The SEC suggested the warrants, typically considered compensation to sponsors for the risks they’ve taken and costs they’ve endured, are not equity. They recommend these be restated as debt in most of the common configurations. This is important as it changes the balance sheet of the operating company and it alters the nature of the warrants, which often trade as equities in addition to SPAC shares.

 

Other Information

It’s important to understand that the SEC is neutral. They want to understand what disclosures investors need so they may make informed investment and voting decisions. It is one of their critical functions to make sure investor information is reliable and not materially misleading (in every securities transaction). They want investors to have unfettered access to information – and then be free to make their own decisions about how to invest or vote. In the case of SPACs, although the SECs high-profile review may have slowed the process, their intent is to make sure all the proper protections are in place.

 

Suggested Reading

Lifecycle of a SPAC

Analysis of a SPAC



Do Microcap Stocks Provide Better Diversification?

SPAC Activity Accelerating in 2020

 

Sources

https://www.sec.gov/news/public-statement/munter-spac-20200331
https://www.cnbc.com/2021/01/30/what-is-a-spac.html

https://www.sec.gov/oiea/investor-alerts-and-bulletins/celebrity-involvement-spacs-investor-alert

https://news.crunchbase.com/news/athletes-and-celebrities-join-the-spac-boom-sec-takes-notice/

https://www.sec.gov/news/public-statement/accounting-reporting-warrants-issued-spacs

https://www.sec.gov/news/public-statement/division-cf-spac-2021-03-31

https://www.sec.gov/corpfin/disclosure-special-purpose-acquisition-companies

https://www.thestreet.com/investing/sec-halts-trading-in-15-firms-due-to-questionable-market-moves

Stay up to date. Follow us:

           


Stay up to date. Follow us:

Release – Aurania Resources Ltd. (AUIAF)(ARU:CA) – Confirms New Discovery That Extends Tiria-Shimpia to 22km


Aurania Confirms New Discovery That Extends Tiria-Shimpia to 22km

Toronto, Ontario, April 30, 2021 – Aurania Resources Ltd. (TSXV: ARU) (OTCQB: AUIAF) (Frankfurt: 20Q) (“Aurania” or the “Company”) reports on the discovery of Shimpia North, an area in which elevated metal values have been found in streams draining a ridge that is seven kilometres (“km”) long.  Shimpia North is an extension to the high-grade silver-zinc-lead mineralization at Tiria-Shimpia in the Company’s Lost Cities – Cutucu Project (“Project”) in southeastern Ecuador.  Shimpia North extends the Tiria-Shimpia target from 15 km to a total length of 22 km.

Outcropping mineralization in the first reconnaissance exploration in this new area gave a grade of 40 grams per tonne (“g/t”) silver in an extensively weathered gossan (iron-rich residue that remains after intense weathering of sulphide-rich rock) and, among other samples, a boulder of barite in a stream returned 19g/t silver, 6.5% lead and 1.1% zinc.

Aurania’s Chairman & CEO, Dr. Keith Barron commented, “Shimpia North appears to have the same character, style and mineralization type as Tiria-Shimpia, though it is displaced to the northwest.  I consider it to be part of the same system. This may be the distal expression of the copper/silver -in-sediment system we have traced further to the south across country for 23 kilometres.  In any case, the Cutucu is proving to be a rare case of a metal-rich basin, that though uplifted and exposed has appeared to not be eroded to significant extent.  The siliceous sinters we find at Kuri-Yawi are evidence of the original land surface in the Jurassic, when we expect the mineralizing event took place.  What I find astounding is that Cretaceous and younger cover rocks have been stripped off to just the right erosional level to expose mineralization.  Otherwise, we would never have guessed it was there.  Equally significant, our very large land parcel has allowed us to piece this story together.  If we had had a postage stamp type parcel, we never would have guessed the magnitude of these mineralizing systems.  Serendipity has worked in our favour.”

Rock-chip and stream sediment sampling that highlights the extent of the mineralized zone, corresponds closely with high potassium detected in radiometric data from the Company’s geophysical survey completed in 2017.  The potassium enrichment feature extends approximately 10 km beyond the area investigated so far (Figure 1), providing an invaluable exploration guide to finding possible further extensions of the mineralized system.  Though it is not yet confirmed, it is believed the potassium mineral is langbeinite, a potassium magnesium sulphate which could potentially occur with the other sulphates like barite, celestite, or gypsum.  The Company has commenced selection of drill sites at the Tiria-Shimpia target area and expects to begin drilling in this quarter.

Geological Details of the Area Sampled at Shimpia North

The mineralization is sediment-hosted, found parallel to the sedimentary layering in limestone intercalated with sandstone.   Hard rock samples contain galena (lead sulphide) and sphalerite (zinc sulphide) with barite (barium sulphate) and celestite (strontium sulphate).   Gossan, weathered rock in which the sulphide minerals have been removed by oxidation to leave an iron oxide residue, has also been encountered.  Although zinc and lead would have been leached out of the gossans, these residues allow us to map out the original extent of the sulphide-rich layers at surface, which could guide us to fresh, sulphide-rich rock below the weathered zone as illustrated in Figure 2.

 

Figure 1.  Image of potassium radiometric data from the geophysical survey that Aurania carried out over the Lost Cities – Cutucu Project in 2017 showing the distribution of silver in rock-chip samples and lead in stream sediment samples.  (Red and purple are areas rich in potassium, blue and green have little potassium). Lead was selected to demonstrate the extent of the Tiria-Shimpia and Shimpia North target areas because it is not easily leached – hence its distribution provides a footprint that is faithful to the extent of the mineralization.

 

Table 1.  Selected analytical results for grab samples of rocks from the Shimpia target (Ag is silver, Pb is lead and Zn is zinc).

 

 

 

Figure 2.  Gossan found on the jungle floor was excavated to reveal fresh, sulphide-bearing mineralization below the weathered layer at Shimpia North.

 

Sample Analysis & Quality Assurance / Quality Control
(“QAQC”)

Laboratories: The stream and rock samples were prepared for analysis at MS Analytical (“MSA”) in Cuenca, Ecuador, and the analyses were done in Vancouver, Canada.

Sample preparation: The rock samples were jaw-crushed to 10 mesh (crushed material passes through a mesh with apertures of 2 millimetres (“mm”)), from which a one-kilogram sub-sample was taken.  The sub-sample was crushed to a grain size of 0.075mm and a 200-gram (“g”) split was set aside for analysis.

The stream sediment samples were wet-sieved through a 20 mesh (0.84mm) screen in the field and placed in cloth bags so that excess water could drain.  The samples were transported from the field to Aurania’s field office in Macas, Ecuador and batched for delivery to at MSA in Cuenca, for drying and screening at 80 mesh (0.18mm sieve aperture).  The -80 mesh silt was packaged by MSA for analysis.

Analytical procedure:  Approximately 0.25g of rock pulp or -80# soil underwent four-acid digestion and analysis for 48 elements by ICP-MS.  For the over-limit samples, those that had a grade of greater than 1% lead and zinc, or 100g/t silver, 0.4 grams of pulp underwent digestion in four acids and the resulting liquid was diluted and analyzed by ICP-MS.

Stream sediment: a 0.5g split of the -80 mesh fraction of the stream silt underwent digestion with aqua regia and the liquid was analyzed for 48 elements by ICP-MS.

Apart from being analyzed by ICP-MS, gold was also analyzed by fire assay with an ICP-AES finish.

QAQC: Aurania personnel inserted a certified standard pulp sample, alternating with a field blank, at approximate 20 sample intervals in all sample batches. Aurania’s analysis of results from its independent QAQC samples showed the batches reported on above, lie within acceptable limits.  In addition, the labs reported that the analyses had passed their internal QAQC tests.

Qualified Person

The geological information contained in this news release has been verified and approved by Jean-Paul Pallier, MSc.  Mr. Pallier is a designated EurGeol by the European Federation of Geologists and a Qualified Person as defined by National Instrument 43-101, Standards of Disclosure for Mineral Projects of the Canadian Securities Administrators.

About Aurania

Aurania is a mineral exploration company engaged in the identification, evaluation, acquisition and exploration of mineral property interests, with a focus on precious metals and copper in South America.  Its flagship asset, The Lost Cities – Cutucu Project, is located in the Jurassic Metallogenic Belt in the eastern foothills of the Andes mountain range of southeastern Ecuador.

Information on Aurania and technical reports are available at www.aurania.com and www.sedar.com, as well as on Facebook at https://www.facebook.com/auranialtd/, Twitter at  https://twitter.com/auranialtd, and LinkedIn at https://www.linkedin.com/company/aurania-resources-ltd-.

 

For further information, please contact:

Carolyn Muir

VP Investor Relations

Aurania Resources Ltd.

(416) 367-3200

[email protected]

 

Dr. Richard Spencer

President

Aurania Resources Ltd.

(416) 367-3200

[email protected]

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release may contain forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurania. Forward-looking statements include estimates and statements that describe Aurania’s future plans, objectives or goals, including words to the effect that Aurania or its management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to Aurania, Aurania provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward looking information in this news release includes, but is not limited to Aurania’s objectives, goals or future plans, statements, exploration results, potential mineralization, the corporation’s portfolio, treasury, management team and enhanced capital markets profile, the estimation of mineral resources, exploration, timing of the commencement of operations and estimates of market conditions. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, failure to identify mineral resources, failure to convert estimated mineral resources to reserves, the inability to complete a feasibility study which recommends a production decision, the preliminary nature of metallurgical test results, delays in obtaining or failures to obtain required governmental, regulatory, environmental or other project approvals, political risks, inability to fulfill the duty to accommodate indigenous peoples, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects, capital and operating costs varying significantly from estimates and the other risks involved in the mineral exploration and development industry, the effects of COVID-19 on the business of the Company including but not limited to the effects of COVID-19 on the price of commodities, capital market conditions, restrictions on labour and international travel and supply chains, and those risks set out in Aurania’s public documents filed on SEDAR. Although Aurania believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Aurania disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Release – Information Services Group (III) – ISG Announces David Berger to Retire as CFO in June; Bert Alfonso Named Executive Vice President and CFO


ISG Announces David Berger to Retire as CFO in June; Bert Alfonso Named Executive Vice President and CFO

 

Alfonso Brings Extensive Financial, Capital Markets and Global M&A Experience to ISG

Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, announced today that David Berger, executive vice president and chief financial officer, will retire after nearly 12 years of service with the firm and that Humberto “Bert” Alfonso has been named to succeed him, effective June 7.

Berger will remain with the firm for several months in an advisory role to assist in ongoing M&A projects and to support the transition. He joined ISG in 2009 as executive vice president and CFO and played a pivotal role in helping grow ISG through his financial stewardship of the firm and his work on a series of strategic acquisitions.

“On behalf of my ISG colleagues, I want to extend my deepest gratitude to David for his long and valued service to ISG,” said Michael P. Connors, chairman and CEO. “David has been a strong partner and advisor to me and our executive team and has made many contributions to our success over the last 12 years, including building a world-class finance and legal organization to support our growth plans. I want to thank David for his thoughtful retirement transition planning and his support over the coming months. We wish him and his family much happiness in their next chapter.”

Alfonso is a global senior executive with over 30 years of operating and finance experience with such distinguished companies as Hershey, Cadbury Schweppes and Pfizer. He spent 10 years with The Hershey Company in executive roles, including chief financial officer and president of Hershey International. Alfonso has a proven track record of driving growth, both organically and through mergers and acquisitions, building high-performance teams and creating shareholder value.

Alfonso will be responsible for all areas of finance, legal affairs and M&A for ISG, reporting to Connors, and will join the ISG executive leadership team.

“I am delighted to welcome Bert to ISG,” said Connors. “Bert and I have known each other for 10 years and I have been impressed with his business acumen and vast array of experience. His global operating leadership as a CEO, his service as a CFO of a multibillion-dollar company, his M&A accomplishments and his experience leveraging technology services to support business operations will be extremely valuable to ISG as we accelerate our growth coming out of the pandemic. Bert’s character, integrity and demeanor are an excellent fit for our growth ambitions.”

Alfonso most recently was the CEO of Yowie Group, a global brand licensing company specializing in the development of consumer products and listed on the Australian Securities Exchange. Prior to Hershey, he was executive vice president and CFO of Cadbury Schweppes Americas beverages and vice president and CFO of the Adams Division of Pfizer.

A native of Cuba, Alfonso has lived in Argentina, Canada, Puerto Rico, the U.K. and the U.S. He holds an MBA degree in marketing and a bachelor’s degree in accounting from Rutgers University. Alfonso is a certified public accountant and serves on the Board of Directors of the NYSE-listed Eastman Chemical Company and is chairman of the Board’s audit committee.

About ISG

ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 700 clients, including more than 75 of the world’s top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,300 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry’s most comprehensive marketplace data. For more information, visit www.isg-one.com.

Source: Information Services Group